JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Velpatasvir (formerly known as GS-5816 or VEL) is a potent, selective, second-generation inhibitor of Hepatitis C virus NS5A. It inhibits hepatitis C viral replication through acting on the crucial 'membranous web' that facilitates RNA replication. Velpatasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A) with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir has demonstrated a high barrier to resistance in HCV replicon assays and a pangenotypic antiviral activity in patients with genotypes 1-4 HCV infection. It is being tested in combination with other pangenotypic direct-acting antivirals to obtain a well-tolerated, highly effective treatment option for all HCV genotypes.
References: Drug Des Devel Ther. 2017 Feb 23; 11:497-502; Antimicrob Agents Chemother. 2016 Aug 22; 60(9):5368-78.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!